Cargando…

Challenging Clinical Perspectives in Type 2 Diabetes with Tirzepatide, a First-in-Class Twincretin

Tirzepatide is a first-in-class GIP/GLP-1 receptor agonist (‘twincretin’)—a single molecule that acts as an agonist at both glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. In the SURPASS clinical trial program in type 2 diabetes mellitus (T2D), tirze...

Descripción completa

Detalles Bibliográficos
Autores principales:	MacIsaac, Richard J., Deed, Gary, D’Emden, Michael, Ekinci, Elif I., Hocking, Samantha, Sumithran, Priya, Rasalam, Roy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597955/ https://www.ncbi.nlm.nih.gov/pubmed/37824027 http://dx.doi.org/10.1007/s13300-023-01475-5

Ejemplares similares

Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?
por: Deed, Gary, et al.
Publicado: (2019)

Efficacy and safety of novel twincretin tirzepatide a dual GIP and GLP-1 receptor agonist in the management of type-2 diabetes: A Cochrane meta-analysis
por: Dutta, Deep, et al.
Publicado: (2021)

Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity
por: Usui, Ryota, et al.
Publicado: (2019)

Individualised prescription of medications for treatment of obesity in adults
por: Hocking, Samantha, et al.
Publicado: (2023)

Exploration of the shared pathophysiological mechanisms of gestational diabetes and large for gestational age offspring
por: Nahavandi, Sofia, et al.
Publicado: (2019)

Scavenger Receptor Class B Member 1 Independent Uptake of Transthyretin by Cultured Hepatocytes Is Regulated by High Density Lipoprotein
por: Landers, Kelly A., et al.
Publicado: (2019)

Improving Type 2 Diabetes Management in General Practice Using a Second-Generation Basal Insulin Analogue Insulin Glargine 300 U/mL: A Practical Guide
por: Deed, Gary, et al.
Publicado: (2019)

Effects of glycaemic management on diabetic kidney disease
por: MacIsaac, Richard J, et al.
Publicado: (2017)

Effectiveness of the cardiac-diabetes transcare program: protocol for a randomised controlled trial
por: Wu, Chiung-Jung (Jo), et al.
Publicado: (2017)

Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective
por: De Block, Christophe, et al.
Publicado: (2022)

Sodium‐glucose cotransporter 2 inhibitor effects on heart failure hospitalization and cardiac function: systematic review
por: Rasalam, Roy, et al.
Publicado: (2021)

Tirzepatide: A Systematic Update
por: Forzano, Imma, et al.
Publicado: (2022)

Adverse Events Related to Tirzepatide
por: Mishra, Rahul, et al.
Publicado: (2023)

Tirzepatide for type 2 diabetes
por: Anderson, Sarah L, et al.
Publicado: (2023)

Response to Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709
por: Ekinci, Elif I., et al.
Publicado: (2011)

Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease
por: Khanijou, Vuthi, et al.
Publicado: (2022)

Advent of tirzepatide: boon for diabetic and obese?
por: Bhusal, Amrit
Publicado: (2023)

Tirzepatide and prevention of chronic kidney disease
por: Bosch, Catalina, et al.
Publicado: (2022)

Tirzepatide-Induced Injection Site Reaction
por: Mizumoto, Junki
Publicado: (2023)

Exploring the Relationship Between Maternal Circulating Hormones and Gestational Weight Gain in Women Without Obesity: A Cross-Sectional Study
por: Lappas, Martha, et al.
Publicado: (2020)

Tirzepatide—Friend or Foe in Diabetic Cancer Patients?
por: Samuel, Samson Mathews, et al.
Publicado: (2022)

The Association Between Sarcopenia and Functional Improvement in Older and Younger Patients Who Completed Inpatient Rehabilitation: A Prospective Cohort Study
por: Churilov, Irina, et al.
Publicado: (2021)

Clinicians' perspectives on gestational diabetes screening during the global COVID‐19 pandemic in Australia
por: Meloncelli, Nina, et al.
Publicado: (2022)

Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP
por: Wang, Lijing
Publicado: (2022)

Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment
por: Pelle, Maria Chiara, et al.
Publicado: (2021)

Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach
por: Batiha, Gaber El-Saber, et al.
Publicado: (2023)

Structural determinants of dual incretin receptor agonism by tirzepatide
por: Sun, Bingfa, et al.
Publicado: (2022)

The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
por: Anala, Alekya Devi, et al.
Publicado: (2023)

Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity
por: Quddos, Fatima, et al.
Publicado: (2023)

Clinical predictive factors in diabetic kidney disease progression
por: Radcliffe, Nicholas J, et al.
Publicado: (2016)

Diagnostic performance of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation at estimating glomerular filtration rate in adults with diabetes mellitus: a systematic review and meta-analysis protocol
por: Zafari, Neda, et al.
Publicado: (2019)

Capillary Triglycerides in Late Pregnancy—Challenging to Measure, Hard to Interpret: A Cohort Study of Practicality
por: Barrett, Helen L., et al.
Publicado: (2021)

Lipid-modifying therapy in the elderly
por: Hamilton-Craig, Ian, et al.
Publicado: (2015)

Development of a fasting blood glucose-based strategy to diagnose women with gestational diabetes mellitus at increased risk of adverse outcomes in a COVID-19 environment
por: d’Emden, Michael, et al.
Publicado: (2020)

Weight loss efficiency and safety of tirzepatide: A Systematic review
por: Lin, Fei, et al.
Publicado: (2023)

Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management
por: Sinha, Rachel, et al.
Publicado: (2023)

Tirzepatide: A Promising Drug for Type 2 Diabetes and Beyond
por: Dutta, Palak, et al.
Publicado: (2023)

Achieving Normoglycemia With Tirzepatide: Analysis of SURPASS 1–4 Trials
por: Rosenstock, Julio, et al.
Publicado: (2023)

Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes
por: Ekinci, Elif I., et al.
Publicado: (2011)

Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate
por: Leong, Amanda, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_76tg4q2urge8t4pg3nnsmn0b89